Caribou Biosciences (CRBU)
(Delayed Data from NSDQ)
$1.69 USD
-0.09 (-5.06%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $1.70 +0.01 (0.59%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth A Momentum D VGM
Fundamental Charts
About Cash from Investing (TTM)
The company's trailing twelve month (TTM) Cash from Investing is the sum of the company's past 12 months cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
CRBU 1.69 -0.09(-5.06%)
Will CRBU be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for CRBU based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CRBU
Biogen Inc. (BIIB) Surpasses Q2 Earnings and Revenue Estimates
Caribou Biosciences (CRBU) Upgraded to Buy: Here's What You Should Know
CRBU: What are Zacks experts saying now?
Zacks Private Portfolio Services
Caribou Biosciences, Inc. (CRBU) Reports Q1 Loss, Misses Revenue Estimates
Will Clearside Biomedical, Inc. (CLSD) Report Negative Q1 Earnings? What You Should Know
Will Caribou Biosciences, Inc. (CRBU) Report Negative Q1 Earnings? What You Should Know
Other News for CRBU
CRBU forms Bollinger Band Squeeze on September 19
Is CRBU signaling a buying opportunity? Stochastic Buy Signal shows up after advancing 3.49%
Is CRBU getting ready to pop? Bollinger Band Squeeze shows up after sliding 4.44%
20 Day Moving Average Resistance appears for CRBU after 1.64% move
NR7 appears for CRBU after 1.67% move